Using biomarkers to monitor multiple sclerosis - On Target Podcast w/ Doug Biehn, President and CEO, Octave Biosciences

Early cancer detection using extracellular vesicles - On Target Podcast w/ Dawn Mattoon, CEO, Mercy BioAnalytics

Dawn Mattoon, CEO of Mercy Bioanalytics, explains how her company is using extracellular vesicles to successfully diagnose early stage cancer.

Using biomarkers to monitor multiple sclerosis - On Target Podcast w/ Doug Biehn, President and CEO, Octave Biosciences

Doug Biehn, President and CEO of Octave Biosciences, talks about the difference that a biomarker test can make in the management of multiple sclerosis.

Identifying hard-to-diagnose infections in cancer patients - On Target Podcast w/ Alec Ford, CEO, Karius

Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised patients battling cancer and other serious conditions.

Advancing multiple-myeloma and blood-cancer dx with WGS - On Target Podcast w/ Irene Ghobrial, Co-Founder, Predicta Biosciences

Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.

"Expanding genomic analysis with optical genome mapping - On Target Podcast w/ Alka Chaubey CMO, Bionano Genomics"

Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.